Changes in Patient Treatment | Before COVID-19 | During COVID-19 | P-value |
---|---|---|---|
Take-home doses |  |  |  < 0.001 |
28-day take-home doses | 6.9% (27) | 24.2% (95) | Â |
14 to 21-day take-home doses | 15.1% (59) | 28.8% (113) | Â |
2 to 7-day take-home doses | 50.5% (198) | 30.9% (121) | Â |
None or 1 take-home doses | 22.4% (88) | 10.2% (40) | Â |
Declined to state | 5.1% (20) | 5.9% (23) | Â |
Clinic attendance |  |  |  < 0.001 |
Never | 0% | 0.8% (3) | Â |
Two or less times a month | 21.2% (83) | 53.3% (209) | Â |
Once a week | 26% (102) | 17.9% (70) | Â |
2–6 times a week | 19.9% (78) | 9.9% (39) |  |
Everyday | 27.8% (109) | 13.5% (53) | Â |
Declined to state | 5.1% (20) | 4.6% (18) | Â |
Drug testing |  |  |  < 0.001 |
Less than once a month | 0.3% (1) | 2.8% (11) | Â |
1–2 times a month | 76.5% (300) | 71.4% (280) |  |
2 or more times a month | 13.3% (52) | 10.5% (41) | Â |
Random | 3.1% (12) | 2.6% (10) | Â |
Never | 1.3% (5) | 9.2% (36) | Â |
Counseling |  |  |  < 0.001 |
In person | 82.9% (325) | 19.4% (76) | Â |
Telehealth | 3.3% (13) | 61.7% (242) | Â |
Not required | 8.2% (32) | 14% (55) | Â |
Decline to state | 5.6% (22) | 4.8% (19) | Â |